Macrophage Transactivation for Chemokine Production Identified as a Negative Regulator of Granulomatous Inflammation Using Agent-Based Modeling

Cellular activation by interferons, cytokines, and chemokines is a commonly recognized mechanism to amplify immune effector function and limit pathogen spread. However, an optimal host response also requires that collateral damage associated with inflammation is limited. This may be particularly so...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in immunology Vol. 9; p. 637
Main Authors Moyo, Daniel, Beattie, Lynette, Andrews, Paul S, Moore, John W J, Timmis, Jon, Sawtell, Amy, Hoehme, Stefan, Sampson, Adam T, Kaye, Paul M
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 27.03.2018
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Cellular activation by interferons, cytokines, and chemokines is a commonly recognized mechanism to amplify immune effector function and limit pathogen spread. However, an optimal host response also requires that collateral damage associated with inflammation is limited. This may be particularly so in the case of granulomatous inflammation, where an excessive number and/or excessively florid granulomas can have significant pathological consequences. Here, we have combined transcriptomics, agent-based modeling, and experimental approaches to study constraints on hepatic granuloma formation in a murine model of experimental leishmaniasis. We demonstrate that chemokine production by non-infected Kupffer cells in the -infected liver promotes competition with infected KCs for available iNKT cells, ultimately inhibiting the extent of granulomatous inflammation. We propose trans-activation for chemokine production as a novel broadly applicable mechanism that may operate early in infection to limit excessive focal inflammation.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Edited by: Takayuki Yoshimoto, Tokyo Medical University, Japan
Reviewed by: Francesco Pappalardo, Università degli Studi di Catania, Italy; Shinichi Hashimoto, Kanazawa University, Japan
Specialty section: This article was submitted to Inflammation, a section of the journal Frontiers in Immunology
Present address: Lynette Beattie, Doherty Institute, University of Melbourne, Melbourne, VIC, Australia
ISSN:1664-3224
1664-3224
DOI:10.3389/fimmu.2018.00637